BDX ASX · Health Care

Bcal Diagnostics Ltd

Announcements, last 12 months: 65
Price sensitive, last 12 months: 19

Latest announcements

Released	Headline	Actions
19 Oct 2026, 2:14 PM	Results of Meeting
19 Oct 2026, 10:43 AM	AGM 2026 Presentation
19 Oct 2026, 9:27 AM	BREASTESTplus Research Presented at Lipidomic Conference
16 Oct 2026, 8:25 PM	Response to Media Speculation & BCAL letter to GSS Price sensitive	AI summary
15 Oct 2026, 2:13 PM	Letter to Genetic Signatures Ltd Shareholders
6 Oct 2026, 10:15 AM	Investor Presentation - Transforming Cancer Detection
1 Oct 2026, 6:23 PM	Change in substantial holding
30 Sep 2026, 8:48 AM	BREASTESTplus 2 clinically validated Price sensitive	AI summary
23 Sep 2026, 10:43 AM	BCAL Introduces Avantect Multi-Cancer Early Detection Test Price sensitive	AI summary
18 Sep 2026, 8:22 AM	Letter to Shareholders re Annual General Meeting

Guidance history

28 Aug 2026

BCAL Diagnostics Ltd expects to progress commercialization in FY27 with increased test adoption.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow BDX to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.